Recent News

• 06.12.2025 - Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
• 06.12.2025 - Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
• 06.05.2025 - Accepting new applications for ACE program 2025
• 05.27.2025 - Court Denies Renovaro Motion for an Expedited Trial in July
• 05.27.2025 - Court Denies Renovaro Motion for an Expedited Trial in July
• 05.22.2025 - AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
• 05.22.2025 - AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
• 05.20.2025 - Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
• 05.20.2025 - Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
• 05.15.2025 - Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update

Recent Filings

• 06.11.2025 - 8-K Current report
• 06.06.2025 - 8-K Current report
• 06.02.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 05.15.2025 - 8-K Current report
• 05.15.2025 - EX-99.1 EX-99.1
• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.18.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 04.18.2025 - 8-K/A Current report